First RSV Vaccine On The Horizon—Pfizer Touts Strong Trial Results As Children’s Hospitals Count Soaring Cases

Topline Pharma giant Pfizer on Tuesday said it would ask regulators to greenlight a vaccine designed to protect infants against respiratory syncytial virus, or RSV, following strong results in late-st...

FTC launches investigation into infant formula shortage

A woman shops for baby formula at Target in Annapolis, Maryland, on May 16, 2022, as a nationwide shortage of baby formula continues due to supply chain crunches tied to the coronavirus pandemic that ...

Pfizer Says Three Shots Of Low-Dose Vaccine Generates ‘Strong Immune Response’ In Kids Under 5

Topline Pfizer and BioNTech on Monday said they will ask the Food and Drug Administration to authorize a three-shot regimen of their Covid-19 vaccine for children under five citing promising clinical ...